These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9476190)

  • 1. The bright liver syndrome. Prevalence and determinants of a "bright" liver echopattern.
    Lonardo A; Bellini M; Tartoni P; Tondelli E
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):351-6. PubMed ID: 9476190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microvesicular steatosis].
    Ionescu DL
    Rev Med Chir Soc Med Nat Iasi; 2002; 107(2):268-72. PubMed ID: 12638271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.
    Loria P; Lonardo A; Lombardini S; Carulli L; Verrone A; Ganazzi D; Rudilosso A; D'Amico R; Bertolotti M; Carulli N
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1176-84. PubMed ID: 16048564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
    Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
    Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic steatohepatitis and the "bright liver syndrome": should a recently expanded clinical entity be further expanded?
    Lonardo A; Bellini M; Tondelli E; Frazzoni M; Grisendi A; Pulvirenti M; Della Casa G
    Am J Gastroenterol; 1995 Nov; 90(11):2072-4. PubMed ID: 7485040
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
    Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
    Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty liver incidence and predictive variables.
    Tsuneto A; Hida A; Sera N; Imaizumi M; Ichimaru S; Nakashima E; Seto S; Maemura K; Akahoshi M
    Hypertens Res; 2010 Jun; 33(6):638-43. PubMed ID: 20379184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
    Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
    Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
    Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
    Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of fasting plasma sulfur-containing compounds with BMI, serum lipids and apolipoproteins.
    Elshorbagy AK; Valdivia-Garcia M; Graham IM; Palma Reis R; Sales Luis A; Smith AD; Refsum H
    Nutr Metab Cardiovasc Dis; 2012 Dec; 22(12):1031-8. PubMed ID: 21550220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.
    Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW
    Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between apolipoprotein E polymorphism, lipoprotein (a) and fatty liver disease.
    Yang MH; Son HJ; Sung JD; Choi YH; Koh KC; Yoo BC; Paik SW
    Hepatogastroenterology; 2005; 52(66):1832-5. PubMed ID: 16334787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin is independently associated with apolipoprotein B to A-1 ratio in Koreans.
    Park JS; Cho MH; Nam JS; Yoo JS; Lee YB; Roh JM; Ahn CW; Jee SH; Cha BS; Lee EJ; Lim SK; Kim KR; Lee HC
    Metabolism; 2010 May; 59(5):677-82. PubMed ID: 19914667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease.
    Rasouli M; Kiasari AM
    Clin Chem Lab Med; 2008; 46(5):667-73. PubMed ID: 18598204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis.
    Palmentieri B; de Sio I; La Mura V; Masarone M; Vecchione R; Bruno S; Torella R; Persico M
    Dig Liver Dis; 2006 Jul; 38(7):485-9. PubMed ID: 16716779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation.
    Onat A; Can G; Hergenç G; Yazici M; Karabulut A; Albayrak S
    Int J Obes (Lond); 2007 Jul; 31(7):1119-25. PubMed ID: 17299378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antibodies to hepatitis C virus in patients with nonalcoholic fatty liver.
    Lin SC; Shih SC; Kao CR; Chou SY
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Aug; 56(2):80-5. PubMed ID: 7553425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.
    Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
    Liver Int; 2009 Jul; 29(6):878-83. PubMed ID: 19192167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.